Autoimmune

Disease

Related News

Clinical Trial Costs and Phases: From Safety Testing to Market Approval

Clinical trials take 10-15 years and cost $1-2 billion from discovery to approval, progressing through four phases from safety testing to real-world monitoring. These studies face challenges including high costs, regulatory oversight, and participant recruitment while new technologies are transforming trial design. Illinois faces a shortage of Phase I clinical trial facilities despite local companies conducting over 50 such trials annually.

Related Clinical Trials

NCT ID Title Status Phase
NCT07727915

"ADEN Platform: Pilot Clinical Validation for Chronic Disease Risk Stratification in Colombia"

ENROLLING_BY_INVITATION
NCT07291323

Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability.

RECRUITING EARLY_PHASE1
NCT07144462

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

RECRUITING EARLY_PHASE1
NCT06626919

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

RECRUITING PHASE1
NCT05984316

Systemic Lupus Erythematosus

RECRUITING NA
NCT05866861

A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus

COMPLETED PHASE1
NCT05697159

7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis

RECRUITING
NCT04872257

Oral Vitamin D Supplementation Combined With Phototherapy as a Treatment for Vitiligo

COMPLETED NA
NCT04618575

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

UNKNOWN PHASE4
NCT03771768

Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease

UNKNOWN NA